These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20950192)

  • 1. Susceptibility of Clostridium difficile toward antimicrobial agents used as feed additives for food animals.
    Aarestrup FM; Tvede M
    Microb Drug Resist; 2011 Mar; 17(1):125-7. PubMed ID: 20950192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
    Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
    Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole resistance in Clostridium difficile.
    Johnson S; Sanchez JL; Gerding DN
    Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.
    Båverud V; Gustafsson A; Franklin A; Aspán A; Gunnarsson A
    Equine Vet J; 2003 Jul; 35(5):465-71. PubMed ID: 12875324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas.
    Norman KN; Scott HM; Harvey RB; Norby B; Hume ME
    Foodborne Pathog Dis; 2014 Apr; 11(4):257-64. PubMed ID: 24320797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occurrence of Clostridium difficile in feces of children with dysfunction of the digestive tract and other disorders].
    Pykiel M; Dzierzanowska D; Stafiej-Modrawska E; Kulesza E; Orłowski L
    Med Dosw Mikrobiol; 1990; 42(1-2):10-4. PubMed ID: 2087130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of intravenous linezolid to treat Clostridium difficile associated diarrhea.
    Lazzarini L; De Lalla F
    J Chemother; 2003 Jun; 15(3):299-300. PubMed ID: 12868561
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
    Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Clostridium difficile isolates from horses in an intensive care unit and association of disease severity with strain type.
    Magdesian KG; Dujowich M; Madigan JE; Hansen LM; Hirsh DC; Jang SS
    J Am Vet Med Assoc; 2006 Mar; 228(5):751-5. PubMed ID: 16506942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.
    Moyenuddin M; Williamson JC; Ohl CA
    Curr Gastroenterol Rep; 2002 Aug; 4(4):279-86. PubMed ID: 12149168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents].
    Wultańska D; Obuch-Woszczatyński P; Pituch H; Luczak M
    Med Dosw Mikrobiol; 2007; 59(2):161-8. PubMed ID: 17929413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
    Blondeau JM
    J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of ermB gene responsible for high level resistance to clindamycin (MLS type resistance) among Clostridium difficile strains isolated from antibiotic associated diarrhea (AAD)].
    Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(1):61-6. PubMed ID: 12908416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
    Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
    Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
    Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
    N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridium difficile-associated diarrhea treated with homologous feces].
    Midtvedt K
    Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1758. PubMed ID: 9621767
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal shedding of antimicrobial-resistant Clostridium difficile strains by dogs.
    Álvarez-Pérez S; Blanco JL; Peláez T; Lanzarot MP; Harmanus C; Kuijper E; García ME
    J Small Anim Pract; 2015 Mar; 56(3):190-5. PubMed ID: 25483272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.